BSE: 532488|NSE: DIVISLAB|ISIN: INE361B01024|SECTOR: Pharmaceuticals
News on Divis Laboratories
Here is why SP Tulsian is bullish on Petronet LNG
7.40 pm | 17 Feb 2017 | Source: CNBC-TV18
SP Tulsian of sptulsian.com, explains why he is bullish on Petronet LNG. He also discusses key pharma sector likes Cadila Healthcare, Divis Laboratori...
Top buzzing midcap stocks to trade on February 6
1.44 pm | 06 Feb 2017 | Source: CNBC-TV18
Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today -- ACC, Ambuja Cement, Bharat Forge, Divis Labs, Accelya Kale, ...
Divi's Vizag plant under Health Canada lens
11.33 am | 30 Jan 2017 | Source: Moneycontrol.com
The Canadian regulator also said it is reviewing – the corrective actions submitted by the company from its regulatory partner. ...
Divis Q3 net likely up 11%, margins may be at 37%
4.51 pm | 27 Jan 2017 | Source: Moneycontrol.com
Street will be squarely focused on commentary on 5 observations co received on its unit 2 by USFDA, inspected from Nov 29 to December 6. Analysts expe...
Quick Links for Divis Laboratories
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.